# Dyne Therapeutics, Inc.: Form DEF 14A, filed Apr 5, 2024

- Company: [Dyne Therapeutics, Inc.](/companies/dyn.md) (CIK 1818794)
- Form: DEF 14A
- Filed: 2024-04-05
- Accepted by EDGAR: Apr 5, 2024, 20:15 ET
- Period: 2024-05-22
- Accession: 0000950170-24-042276
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1818794/000095017024042276/2024_proxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818794/000095017024042276/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818794/000095017024042276/2024_proxy.htm

Filed Apr 5, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-042276. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.